CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 35.20
0.00 (0.00%)
Apr 17, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 14.08 billion as of April 17, 2026. Its market cap has increased by 19.69% in one year.
Market Cap
14.08B
Enterprise Value
12.58B
Revenue
1.19B
Ranking
n/a
PE Ratio
287.56
Stock Price
35.20
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 14.08B, an increase of 86.01%. That is a compound annual growth rate of 9.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 14.08B | 11.49% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunshine Lake Pharma | 25.36B |
| Grand Pharmaceutical Group | 23.67B |
| The United Laboratories International Holdings | 19.81B |
| Fujian Haixi Pharmaceuticals | 15.36B |
| Consun Pharmaceutical Group | 13.73B |
| Sihuan Pharmaceutical Holdings Group | 12.03B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Luye Pharma Group | 11.46B |